Internal Medicine, Medical Oncology · Homestead, FL
NPI
1780711531
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
151 NW 11th St Ste E304
Homestead, FL, 33030
Phone (786) 504-3084
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.4M
61,399 services
Medicare patients, 2024
143
Average age 71
Drug cost, 2024
$3.0M
1,205 prescriptions
Company payments, 2025
$2,255
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tony N Talebi was code J2916 (injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg), 1,620 times for 18 patients. In total Tony N Talebi billed 61,399 services in 74 codes, and Medicare paid $1.4M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-20.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | Office | 1,620 | 18 | $1.73 | $2,801 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,272 | 16 | $0.09 | $114 |
| 99213 Office E&M - Established | Office | 681 | 63 | $73.44 | $50K |
| 36415 Venipuncture Blood Collection | Office | 524 | 116 | $8.65 | $4,533 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 400 | 11 | $0.65 | $260 |
| 96367 Intravenous Infusion, Hydration | Office | 335 | 28 | $22.96 | $7,692 |
| 96365 Intravenous Infusion, Hydration | Office | 224 | 22 | $50.52 | $11K |
| 96415 Chemotherapy Administration | Office | 223 | 20 | $22.74 | $5,071 |
| 96413 Chemotherapy Administration | Office | 216 | 24 | $105.72 | $23K |
| 99442 Telephone Services | Office | 209 | 76 | $72.56 | $15K |
| 96372 Injection Administration | Office | 206 | 23 | $11.48 | $2,364 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 167 | 26 | $0.65 | $108 |
| 96375 Injection Administration | Office | 101 | 15 | $12.50 | $1,262 |
| 99214 Office E&M - Established | Office | 64 | 51 | $99.31 | $6,356 |
| 99205 Office E&M - New | Office | 57 | 57 | $167.76 | $9,562 |
By year: 2022 $1.1M for 93,854 services; 2023 $1.1M for 52,217 services; 2024 $1.4M for 61,399 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 524 | 116 | $8.65 | $4,533 |
Medicare prescription drug claims, 2024
In 2024, the drug Tony N Talebi prescribed most often to Medicare patients was Hydroxyurea, with 131 prescriptions and refills. In total Tony N Talebi wrote 1,205 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 131 | 162 | 19 | $1,938 |
| Anastrozole Generic | 114 | 237 | 36 | $1,355 |
| Eliquis Apixaban | 105 | 125 | 25 | $70K |
| Ondansetron Odt Ondansetron | 75 | 77 | 39 | $1,438 |
| Prednisone Generic | 69 | 81 | 21 | $292 |
| Acyclovir Generic | 69 | 128 | 16 | $566 |
| Lenalidomide Generic | 47 | 47 | Under 11 | $710K |
| Zarxio Filgrastim-Sndz | 33 | 33 | Under 11 | $51K |
| Bicalutamide Generic | 32 | 73 | 11 | $1,150 |
| Sodium Polystyrene Sulfonate Generic | 27 | 27 | 17 | $614 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 27 | 27 | Under 11 | $537 |
| Imatinib Mesylate Generic | 27 | 27 | Under 11 | $13K |
| Sprycel Dasatinib | 24 | 24 | Under 11 | $424K |
| Tramadol Hcl Generic | 24 | 24 | Under 11 | $359 |
| Jakafi Ruxolitinib Phosphate | 21 | 21 | Under 11 | $196K |
Brand drugs: 356 claims; generic drugs: 849 claims; opioid claims: 85.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tony N Talebi $2,255 ($2,255 in general payments such as food, travel and fees) from 34 companies. The largest payer was Merck Sharp & Dohme LLC with $246.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 10 | $246 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $230 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $165 |
| Daiichi Sankyo Inc. 4568.T | 7 | $153 |
| Alexion Pharmaceuticals, Inc. AZN | 5 | $138 |
| Celgene Corporation BMY | 6 | $137 |
| Abbvie Inc. ABBV | 4 | $93.84 |
| Genzyme Corporation SNY | 4 | $82.19 |
| Janssen Biotech, Inc. JNJ | 4 | $78.86 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $77.66 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.